申请人:Piramal Enterprises Limited
公开号:US10273230B2
公开(公告)日:2019-04-30
The present invention relates to substituted phenyl alkanoic acid compounds designated as the compound of Formula (I) (as described herein) or a tautomer, a stereoisomer, a geometrical isomer, a pharmaceutically acceptable salt, a pharmaceutically acceptable solvate, a prodrug, a polymorph, an N-oxide, a S-oxide or a carboxylic acid isostere thereof; which are GPR120 agonists. The present invention also relates to a pharmaceutical composition of compound of Formula (I) for the treatment of diseases or disorder mediated by GPR120.
本发明涉及被命名为式(I)化合物(如本文所述)的取代苯基烷酸化合物或其同分异构体、立体异构体、几何异构体、药学上可接受的盐、药学上可接受的溶液、原药、多晶型、N-氧化物、S-氧化物或羧酸异构体;它们是 GPR120 激动剂。本发明还涉及一种式(I)化合物的药物组合物,用于治疗由 GPR120 介导的疾病或紊乱。